SAN CARLOS, CA, Earflo, a medical technology company developing a non-invasive, at-home treatment for negative middle ear pressure in children as young as two, announced a $415,000 social-mission investment.
Earflo, a medical technology company developing a non-invasive, at-home treatment for negative middle ear pressure in children as young as two, announced a $415,000 social-mission investment from the Richard King Mellon Foundation. The funds will support FDA clearance, manufacturing, and launch preparation efforts to bring Earflo's at-home solution to families.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
